Susen Burock

Berlin, BE 10117, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial.

Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial.

Journal: Neurological research and practice

Published: January 28, 2024

Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life Expectancy.

Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life Expectancy.

Journal: Cancers

Published: December 27, 2023

IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).

IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).

Journal: Trials

Published: September 11, 2023

Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer".

Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer".

Journal: EBioMedicine

Published: July 22, 2023

Fighting Post-COVID and ME/CFS - development of curative therapies.

Fighting Post-COVID and ME/CFS - development of curative therapies.

Journal: Frontiers in medicine

Published: March 27, 2023

Dissecting the genetic heterogeneity of gastric cancer.

Dissecting the genetic heterogeneity of gastric cancer.

Journal: EBioMedicine

Published: December 21, 2022

Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform.

Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform.

Journal: European journal of epidemiology

Published: October 13, 2022

Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival.

Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival.

Journal: Cancers

Published: February 21, 2022

Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.

Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 19, 2022

SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests.

SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests.

Journal: Microbiology spectrum

Published: January 05, 2022

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.

Journal: Oncogene

Published: December 19, 2021

Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.

Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.

Journal: British journal of cancer

Published: October 31, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026